跳至主要内容
临床试验/NCT02757404
NCT02757404已完成4 期

Impact of Injection Techniques on the Effectiveness of Botulinum Toxin for the Treatment of Post Stroke Upper Limb Spasticity

Medy-Tox0 个研究点目标入组 59 人开始时间: 2016年5月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
59
主要终点
Comparison evaluation on improvement rate of spasticity assessed by Modified Ashworth Scale between 3 arms.

研究概览

简要总结

Botulinum Toxin for the Treatment of Post Stroke Upper Limb Spasticity.

详细描述

This study is "A Multicenter, Prospective, Randomized, Evaluator Blinded, Comparing Phase 4 Study to Evaluate the Impact of Injection Techniques on the Effectiveness of Botulinum Toxin for the Treatment of Post Stroke Upper Limb Spasticity".

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female subject aged over
  • Subjects who has grade 1 + and more spasticity at least one of upper limb muscles as measured on Modified Ashworth Scale after stroke.
  • Subjects who was diagnosed stroke at least 1 month prior to study participation.
  • Subjects or legal representatives who voluntarily decided the participation of the study and signed the informed consent.

排除标准

  • Subjects who had spinal injuries to be a factor of spasticity except for stroke prior to study enrollment.
  • Subjects with allergy or hypersensitivity to the Botulinum Toxin.
  • Subjects who have changed the muscle relaxant taking for treatment within past 4 weeks prior to study participation.
  • Subjects who have taken injection treatments using alcohol or phenol in upper limb within past 6 months prior to study participation.
  • Subjects with general neuromuscular synaptic disorder(e.g. Myasthenia gravis, Lambert-Eaton syndrome, Amyotrophic lateral sclerosis).
  • Subjects who have been injected with botulinum toxin within past 3 months before the injection.
  • Subjects who are pregnant or lactating of disagreed to avoid pregnancy during 3 months study period.
  • Subjects who are scheduled to take part in other clinical trial during the study period.
  • Patients who are not eligible for this study at the medical discretion of the investigator.

研究组 & 干预措施

Ultrasonography guidance

Experimental

Ultrasonography guidance injection of Meditoxin®.

干预措施: Ultrasonography guidance injection of Meditoxin®. (Drug)

Electrical stimulation guidance

Experimental

Electrical stimulation guidance injection of Meditoxin®.

干预措施: Electrical stimulation guidance injection of Meditoxin®. (Drug)

Manual needle placement

Experimental

Manual needle placement injection of Meditoxin®.

干预措施: Manual needle placement injection of Meditoxin®. (Drug)

结局指标

主要结局

Comparison evaluation on improvement rate of spasticity assessed by Modified Ashworth Scale between 3 arms.

时间窗: 4 weeks

次要结局

  • Comparison evaluation on improvement rate of spasticity assessed by Modified Tardieu Scale between 3 arms.(4 weeks)
  • Comparison evaluation on improvement rate of range of motion on each joint between 3 arms.(4 weeks)

研究者

发起方
Medy-Tox
申办方类型
Industry
责任方
Sponsor

相似试验

Meditoxin® Treatment in Patients With Post Stroke... | 临床试验